Boost from Covid jab is wearing off at BioNTech – The Times

One of the leading producers of coronavirus vaccines has slashed its annual revenue forecasts by about 1 billion as demand continues to wane.

BioNTech yesterday forecast that it would generate about 4 billion in sales from Covid vaccines in 2023, lower than a prediction of 5 billion issued in March and sharply down on the 17.2 billion achieved last year. It cited lower demand for booster shots and first doses, as well as delayed national vaccination programmes.

The German company, which teamed up with Pfizer, the American drugs group, for the jab, is the latest vaccine maker to cut forecasts alongside trading updates. Last week Pfizer fell to its first quarterly loss since 2019 and confirmed a $5.6 billion one-off charge after recently agreeing for

Follow this link:

Boost from Covid jab is wearing off at BioNTech - The Times

Related Posts
Tags: